Press release: Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate Cardiomyocytes to Advance Cardiac Safety Research
Press release: Ncardia launches Ncyte® Heart in a Box
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
INSPIRE: A European safety pharmacology training network
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
